Gene · 3158
Papers1,554
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,554
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 37373553 | PubTator, text mining | PubMed |
| The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape. | Cell Commun Signal | 2023 | 37370164 | PubTator, text mining | PubMed |
| An RNA-immunoprecipitation via CRISPR/dCas13 reveals an interaction between the SARS-CoV-2 5'UTR RNA and the process of human lipid metabolism. | Sci Rep | 2023 | 37369697 | PubTator, text mining | PubMed |
| The lipogenic enzyme acetoacetyl-CoA synthetase and ketone body utilization for denovo lipid synthesis, a review. | J Lipid Res | 2023 | 37356666 | PubTator, text mining | PubMed |
| Advanced Progression for the Heterogeneity and Homeostasis of Intestinal Stem Cells. | Stem Cell Rev Rep | 2023 | 37351833 | PubTator, text mining | PubMed |
| Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma. | Cancer Res | 2023 | 37350667 | PubTator, text mining | PubMed |
| Multimodal single-cell analysis of nonrandom heteroplasmy distribution in human retinal mitochondrial disease. | JCI Insight | 2023 | 37289546 | PubTator, text mining | PubMed |
| Targeting HMG-CoA synthase 2 suppresses tamoxifen-resistant breast cancer growth by augmenting mitochondrial oxidative stress-mediated cell death. | Life Sci | 2023 | 37276910 | PubTator, text mining | PubMed |
| Withaferin A: A Pleiotropic Anticancer Agent from the Indian Medicinal Plant Withania somnifera (L.) Dunal. | Pharmaceuticals (Basel) | 2023 | 37259311 | PubTator, text mining | PubMed |
| The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy. | Front Pharmacol | 2023 | 37251321 | PubTator, text mining | PubMed |
| Integrative analysis reveals marker genes for intestinal mucosa barrier repairing in clinical patients. | iScience | 2023 | 37250791 | PubTator, text mining | PubMed |
| Adipose tissue plasticity in pheochromocytoma patients suggests a role of the splicing machinery in human adipose browning. | iScience | 2023 | 37250773 | PubTator, text mining | PubMed |
| Adipolin protects against renal injury via PPARα-dependent reduction of inflammasome activation. | iScience | 2023 | 37250342 | PubTator, text mining | PubMed |
| Role of Sirtuin 3 in Degenerative Diseases of the Central Nervous System. | Biomolecules | 2023 | 37238605 | PubTator, text mining | PubMed |
| Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma. | Front Immunol | 2023 | 37234166 | PubTator, text mining | PubMed |
| A coordinated multiorgan metabolic response contributes to human mitochondrial myopathy. | EMBO Mol Med | 2023 | 37222423 | PubTator, text mining | PubMed |
| Fatty acids metabolism affects the therapeutic effect of anti-PD-1/PD-L1 in tumor immune microenvironment in clear cell renal cell carcinoma. | J Transl Med | 2023 | 37221577 | PubTator, text mining | PubMed |
| USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer. | Cell Death Differ | 2023 | 37202505 | PubTator, text mining | PubMed |
| Anti-apoptotic genes and non-coding RNAs are potential outcome predictors for ulcerative colitis. | Funct Integr Genomics | 2023 | 37199828 | PubTator, text mining | PubMed |
| Ligand dependent interaction between PC-TP and PPARδ mitigates diet-induced hepatic steatosis in male mice. | Nat Commun | 2023 | 37173315 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3158/papers?page=11